Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Thrm closes their pp

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Aug 08, 2020 12:38pm

107 Views

Post# 31382873

RE:RE:RE:RE:Thrm closes their pp

Do your homework...they have 1.4 million in the bank....they have plenty of cash !!!

luvhorses wrote: So, essentially, v.VXL will soon be running out of $$$...they have no $$$ to do any further research or anything else!

This is going to .075 in a hurry by the end of next week :(

Hiker, still not too late to get into my c.SPMT.....make back your v.VXL losses via SPMT...watch it move next week :))